Endo, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NDOI
Endo, INCDEFA14A: Endo, Inc. Issues Supplemental Disclosures Amid Shareholder Lawsuits Challenging Mallinckrodt Merger
Endo, Inc. has filed supplemental disclosures to its definitive proxy statement in response to shareholder complaints and demand letters challenging its proposed merger with Mallinckrodt plc, aiming to moot claims and avoid transaction delays.
NDOI
Endo, INCEndo, Inc. has released its definitive proxy statement outlining proposals for its 2025 Annual Meeting, including director elections, executive compensation, and the appointment of its independent auditor, while highlighting strong 2024 financial and operational performance following its Chapter 11 reorganization.
NDOI
Endo, INCMallinckrodt is set to acquire Endo, pending shareholder and regulatory approvals, in a deal that will reshape both companies and potentially lead to a NYSE listing for the combined entity.